Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.

Markus C Stühlinger; Olaf Stanger

Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.

Markus C Stühlinger, Olaf Stanger

Department of Cardiac Surgery (until 29th of August, 2018)

Research output: Contribution to journal › Review article › peer-review

83 Citations (Web of Science)

Original language	English
Pages (from-to)	3-14
Journal	CURRENT DRUG METABOLISM
Volume	6
Issue number	1
Publication status	Published - 2005

Keywords

NITRIC-OXIDE SYNTHASE
CORONARY-ARTERY-DISEASE
FOLIC-ACID TREATMENT
PLASMA HOMOCYSTEINE CONCENTRATION
STAGE RENAL-DISEASE
SMOOTH-MUSCLE
RISK-FACTOR
VASCULAR-DISEASE
DEPENDENT VASODILATION
ENDOGENOUS INHIBITOR

Cite this

Stühlinger, M. C., & Stanger, O. (2005). Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. CURRENT DRUG METABOLISM , 6(1), 3-14.

Stühlinger, Markus C ; Stanger, Olaf. / Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. In: CURRENT DRUG METABOLISM 2005 ; Vol. 6, No. 1. pp. 3-14.

@article{62635e6dd3bc4d45aec072efbc055874,

title = "Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.",

keywords = "NITRIC-OXIDE SYNTHASE, CORONARY-ARTERY-DISEASE, FOLIC-ACID TREATMENT, PLASMA HOMOCYSTEINE CONCENTRATION, STAGE RENAL-DISEASE, SMOOTH-MUSCLE, RISK-FACTOR, VASCULAR-DISEASE, DEPENDENT VASODILATION, ENDOGENOUS INHIBITOR",

author = "St{\"u}hlinger, {Markus C} and Olaf Stanger",

year = "2005",

language = "English",

volume = "6",

pages = "3--14",

journal = "CURRENT DRUG METABOLISM ",

issn = "1389-2002",

number = "1",

}

Stühlinger, MC & Stanger, O 2005, 'Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.', CURRENT DRUG METABOLISM , vol. 6, no. 1, pp. 3-14.

Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. / Stühlinger, Markus C; Stanger, Olaf.
In: CURRENT DRUG METABOLISM , Vol. 6, No. 1, 2005, p. 3-14.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.

AU - Stühlinger, Markus C

AU - Stanger, Olaf

PY - 2005

Y1 - 2005

KW - NITRIC-OXIDE SYNTHASE

KW - CORONARY-ARTERY-DISEASE

KW - FOLIC-ACID TREATMENT

KW - PLASMA HOMOCYSTEINE CONCENTRATION

KW - STAGE RENAL-DISEASE

KW - SMOOTH-MUSCLE

KW - RISK-FACTOR

KW - VASCULAR-DISEASE

KW - DEPENDENT VASODILATION

KW - ENDOGENOUS INHIBITOR

M3 - Review article

C2 - 15720202

SN - 1389-2002

VL - 6

SP - 3

EP - 14

JO - CURRENT DRUG METABOLISM

JF - CURRENT DRUG METABOLISM

IS - 1

ER -

Stühlinger MC, Stanger O. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. CURRENT DRUG METABOLISM . 2005;6(1):3-14.